Therein, a VAS was used to demonstrate statistically significant and clinically relevant pain improvement with OMT in patients with chronic low back pain. 3 In fact, VAS pain scores were sufficiently robust to demonstrate a large OMT effect in the subgroup of patients with moderate to severe levels of baseline low back pain. 4 Beyond these statistically significant and clinically relevant pain reductions with OMT in the OSTEOPATHIC Trial, it was also shown that patients in the OMT group less frequently used prescription medication for low back pain than did patients in the sham OMT group, even after controlling for multiple potential confounders. 3 Notably, in the OSTEOPATHIC Trial (unlike the AOA-CAP program), medication for low back pain was independently prescribed by physicians who were not part of the investigative team and, therefore, were blinded to patient treatment alloca- to contaminated cannabis use. 7 In that case, the individual smoked contaminated cannabis 48 to 72 hours before the onset of symptoms. 7 Our patient intermittently used cannabis and did not have a recurrence of symptoms after every use as described in the mentioned case report.
In conclusion, the exact etiologic process of our patient's myopericarditis may never be determined. However, the annual recurrence of symptoms within the same
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We appreciate the comments and expertise of Chhabra et al. 1 The interesting aspect of our case 2 was the timing of the recurrent symptoms. However, the recurrent annual presentation such as the one described in our case 2 has not been previously reported in the literature, to our knowledge. By definition, seasonal occurrence is occurrence at the same time of the year. An example of a disorder with seasonal occurrence is seasonal affective disorder, which is depression that occurs during a specific season of the year, most often winter. 4 On the basis of this definition, we believe our description of "seasonal recurrent myopericarditis" is accurate.
We agree with Chhabra et al 1 
